Eli Lilly & Company (NYSE: LLY)
DRUGS - Drug Manufacturers - MajorSector: Health Care
Stock price data as of 12/23/2022
Closing price: 367.90
Support price level: | $357.61 |
Resistance price level: | N/A |
Relative strength index (14-day RSI) | 48.8 |
Beta | 0.50 |
- LLY is at or near its 52-week high. Studies have found that such stocks have an increased probability of outperforming the market over the next year.
- With a 34.7 percent return in the past year, this stock outperformed 90 percent of stocks in the S&P-100.
- Volatility is forecast to fall over the next month.
- Price broke above prior resistance level - a short-term bullish signal.
Low | High | Price as % of Range |
$234.69 | $374.76 | 96.1% |
200 day | 50 day | 20 day | 10 day |
$320.07 | $358.46 | $365.82 | $362.79 |
Historical (5 year) |
Last month | Current estimate | Next month forecast |
28.1% | 28.1% | 25.5% | 26.2% |
- 6.9% in the next week.
- 14.8% in the next month.
- 55.7% in the next year.
Company news for Eli Lilly & Company
Google Finance |
MarketWatch |
WSJ
Analysis for other Health Care stocks